Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis
INFLUENZA AND OTHER RESPIRATORY VIRUSES, vol.10, no.3, pp.192-204, 2016 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 10 Issue: 3
- Publication Date: 2016
- Doi Number: 10.1111/irv.12363
- Journal Name: INFLUENZA AND OTHER RESPIRATORY VIRUSES
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.192-204
- Keywords: Hospitalisation, individual participant data meta-analyses, influenza-related pneumonia, neuraminidase inhibitors, RISK-FACTORS, A H1N1, OSELTAMIVIR TREATMENT, ANTIVIRAL TREATMENT, VIRUS-INFECTION, OUTCOMES, HOSPITALIZATION, ADULTS, COMPLICATIONS
- Hacettepe University Affiliated: Yes
Abstract
BackgroundThe impact of neuraminidase inhibitors (NAIs) on influenza-related pneumonia (IRP) is not established. Our objective was to investigate the association between NAI treatment and IRP incidence and outcomes in patients hospitalised with A(H1N1)pdm09 virus infection.